Company Search:
Advanced Search
Sponsored Links
Arcticzymes Technologies ASA Company Snapshot
Arcticzymes Technologies ASA operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Arcticzymes Technologies ASA with three other pharmaceutical manufacturers in Europe: Diod PAO of RUSSIAN FEDERATION (2019 sales of 657.75 million Russian Rubles [US$8.42 million] ), Nicox SA of FRANCE (6.86 million Euros [US$7.97 million] ), and Norda ASA (83.94 million Norwegian Kroner [US$8.77 million] ).

Sales Analysis. During the year ended December of 2019, sales at Arcticzymes Technologies ASA were NOK 77.25 million (US$8.07 million). This is an increase of 15.7% versus 2018, when the company's sales were NOK 66.77 million. Sales of Enzymes saw an increase that was more than double the company's growth rate: sales were up 31.7% in 2019, from NOK 34.30 million to NOK 45.19 million. Not all segments of Arcticzymes Technologies ASA experienced an increase in sales in 2019: sales of Betaglucans fell 1.2% to NOK 32.06 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Arcticzymes Technologies ASA
  Stock Performance Chart for Arcticzymes Technologies ASA
  Stock Data: Recent Stock Performance:
  Current Price (9/25/2020): 58.20
(Figures in Norwegian Kroner)
1 Week -1.4%   13 Weeks -11.0%  
4 Weeks 94.0%   52 Weeks 1,302.4%  
Arcticzymes Technologies ASA Key Data:
  Ticker: AZT Country: Norway
  Exchanges: OSL Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 77,247,000
(Year Ending Jan 2020).
Employees: 38
  Currency: Norwegian Kroner Market Cap: 2,813,077,969
  Fiscal Yr Ends: December Shares Outstanding: 48,334,673
  Share Type: Ordinaere Aksje Closely Held Shares: 15,148,265
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.